Disciplines

Integrative Biology | Neuroscience and Neurobiology

Abstract (300 words maximum)

Accurate control of nervous system development is critical for normal brain patterning, and defects in this process can lead to neurological disorders such as schizophrenia and Autism Spectrum Disorder. The transcription factor neurogenin is necessary for the development of neural subtypes and is deeply conserved across species. However, the transcriptional targets of neurogenin are poorly understood, creating an imperative for further study. We have used the nematode Caenorhabditis elegans as a model to better understand ngn-1/neurogenin function. Previous work from our lab revealed that ngn-1 plays a role in nerve ring architecture, and neural cell fate specification. In addition, ngn-1 mutants have an array of neuromuscular defects such as sluggish, uncoordinated movement and precocious egg laying. To help identify downstream targets of ngn-1, we performed a comparative transcriptome on messenger RNA isolated from wild type and ngn-1 mutants. We discovered that F07A5.4 transcript levels are significantly lower in ngn-1 mutants. F07A5.4 is an ortholog of Human olfactomedin (Olfm1), which is a secreted glycoprotein in the conserved olfactomedin family (OLF). In rodents, OLF domain proteins play important roles in neurogenesis, neural crest formation, and cell adhesion. We hypothesize that F07A5.4 is required for establishing normal nervous system architecture in the worm. To investigate this, we have identified alleles from the Million Mutation Project that mutate conserved amino acids in the F07A5.4 protein sequence. This project aims to characterize the phenotype of those alleles and to establish the normal function of F07A5.4 in C. elegans nervous system development.

Academic department under which the project should be listed

Molecular and Cellular Biology

Primary Investigator (PI) Name

Martin Hudson

Share

COinS
 

Characterization of Caenorhabditis Elegans F07A5.4, Human Ortholog of Olfactomedin 1

Accurate control of nervous system development is critical for normal brain patterning, and defects in this process can lead to neurological disorders such as schizophrenia and Autism Spectrum Disorder. The transcription factor neurogenin is necessary for the development of neural subtypes and is deeply conserved across species. However, the transcriptional targets of neurogenin are poorly understood, creating an imperative for further study. We have used the nematode Caenorhabditis elegans as a model to better understand ngn-1/neurogenin function. Previous work from our lab revealed that ngn-1 plays a role in nerve ring architecture, and neural cell fate specification. In addition, ngn-1 mutants have an array of neuromuscular defects such as sluggish, uncoordinated movement and precocious egg laying. To help identify downstream targets of ngn-1, we performed a comparative transcriptome on messenger RNA isolated from wild type and ngn-1 mutants. We discovered that F07A5.4 transcript levels are significantly lower in ngn-1 mutants. F07A5.4 is an ortholog of Human olfactomedin (Olfm1), which is a secreted glycoprotein in the conserved olfactomedin family (OLF). In rodents, OLF domain proteins play important roles in neurogenesis, neural crest formation, and cell adhesion. We hypothesize that F07A5.4 is required for establishing normal nervous system architecture in the worm. To investigate this, we have identified alleles from the Million Mutation Project that mutate conserved amino acids in the F07A5.4 protein sequence. This project aims to characterize the phenotype of those alleles and to establish the normal function of F07A5.4 in C. elegans nervous system development.